1.
|
Adham M, Kurniawan AN, Muhtadi AI, et al:
Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence,
signs and symptoms at presentation. Chin J Cancer. 31:185–196.
2012. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Huang TR, Zhang SW, Chen WQ, et al: Trends
in nasopharyngeal carcinoma mortality in China, 1973–2005. Asian
Pac J Cancer Prev. 13:2495–2502. 2012.PubMed/NCBI
|
3.
|
Li JX, Lu TX, Huang Y and Han F: Clinical
characteristics of recurrent nasopharyngeal carcinoma in
high-incidence area. Scientific World Journal. Feb 1–2012.(Epub
ahead of print).
|
4.
|
Teo P, Yu P, Lee WY, et al: Significant
prognosticators after primary radiotherapy in 903 nondisseminated
nasopharyngeal carcinoma evaluated by computer tomography. Int J
Radiat Oncol Biol Phys. 36:291–304. 1996. View Article : Google Scholar
|
5.
|
Geara FB, Sanguineti G, Tucker SL, et al:
Carcinoma of the nasopharynx treated by radiotherapy alone:
determinants of distant metastasis and survival. Radiother Oncol.
43:53–61. 1997. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Sanguineti G, Geara FB, Garden AS, et al:
Carcinoma of the nasopharynx treated by radiotherapy alone:
determinants of local and regional control. Int J Radiat Oncol Biol
Phys. 37:985–996. 1997. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Erkal HS, Serin M and Cakmak A:
Nasopharyngeal carcinomas: analysis of patient, tumor and treatment
characteristics determining outcome. Radiother Oncol. 61:247–256.
2001. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Zhao C, Lu TX, Han F, et al: Clinical
study of 139 nasopharyngeal carcinoma patients for intensity
modulated radiation therapy. Chin J Radiat Oncol. 15:1–6. 2006.
|
9.
|
Tham IW and Lu JJ: Controversies and
challenges in the current management of nasopharyngeal cancer.
Expert Rev Anticancer Ther. 10:1439–1450. 2010. View Article : Google Scholar : PubMed/NCBI
|
10.
|
Tombolini V, De Sanctis V, Donato V, et
al: Prognostic features and treatment outcome in patients with
nasopharyngeal carcinoma: an experience of 20 years. Anticancer
Res. 21:1413–1418. 2001.PubMed/NCBI
|
11.
|
Wang XS, Hu CS, Wu YR and Feng Y:
Influence of speed in tumor regression on prognosis of
nasopharyngeal carcinoma. Chin J Radiat Oncol. 14:6–9. 2005.
|
12.
|
Lu H and Yao M: The current status of
intensity-modulated radiation therapy in the treatment of
nasopharyngeal carcinoma. Cancer Treat Rev. 34:27–36. 2008.
View Article : Google Scholar : PubMed/NCBI
|
13.
|
Leung TW, Tung SY, Sze WK, et al:
Treatment results of 1070 patients with nasopharyngeal carcinoma:
an analysis of survival and failure patterns. Head Neck.
27:555–565. 2005. View Article : Google Scholar : PubMed/NCBI
|
14.
|
Zhu DG, Qian LT, Zhang HY, et al:
Therapeutic effect and prognostic analysis of 164 cases of
nasopharyngeal carcinoma after radiotherapy. Acta Univ Medi Anhui.
45:535–538. 2010.
|
15.
|
Chien CR, Lin HW, Yang CH, et al: High
case volume of radiation oncologists is associated with better
survival of nasopharyngeal carcinoma patients treated with
radiotherapy: a multifactorial cohort analysis. Clin Otolaryngol.
36:558–565. 2011.
|
16.
|
Liu MT, Hsieh CY, Chang TH, et al:
Prognostic factors affecting outcome of nasopharyngeal carcinoma.
Jpn J Clin Oncol. 33:501–508. 2003. View Article : Google Scholar : PubMed/NCBI
|
17.
|
McMillan AS, Pow EH, Kwong DL, et al:
Preservation of quality of life after intensity-modulated
radiotherapy for early-stage nasopharyngeal carcinoma: results of a
prospective longitudinal study. Head Neck. 28:712–722. 2006.
View Article : Google Scholar
|
18.
|
Han L, Lin SJ, Pan JJ, et al: Prognostic
factors of 305 nasopharyngeal carcinoma patients treated with
intensity-modulated radiotherapy. Chin J Cancer. 29:153–158.
2010.PubMed/NCBI
|
19.
|
Kwong DL, Sham JS, Chua DT, et al: The
effect of interruptions and prolonged treatment time in
radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol
Phys. 39:703–710. 1997. View Article : Google Scholar : PubMed/NCBI
|
20.
|
O’Meara WP and Lee N: Advances in
nasopharyngeal carcinoma. Curr Opin Oncol. 17:225–230. 2005.
|